The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a company-led recall for Imatinib 400mg Capsules.
Cipla (EU) Limited has informed the MHRA that there is an error on the Patient Information Leaflet (PIL) for Imatinib 400mg Capsules: the dosage information for the indication CML is incorrect.
Further details of the alert, including the affected batch, and action to take are available on the MHRA website.